Coherus Oncology (CHRS) Non-Current Debt (2016 - 2026)
Coherus Oncology's Non-Current Debt came in at $37.25 million for Q2 2026, up 1.0% from $36.87 million a year earlier and up 0.3% from the prior quarter.
Coherus Oncology (CHRS) Non-Current Debt (2016 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology's Non-Current Debt was $37.05 million, up 1.0% from FY2024.
- Non-Current Debt carries a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- Going back by year, Non-Current Debt was $36.7 million in FY2024 (-85.1%), $246.48 million in FY2023 (+0.4%), $245.48 million in FY2022 (+225.1%) and $75.51 million in FY2021 (+1.4%).
- The Q2 2026 figure represents the highest quarterly Non-Current Debt since Q1 2024.
- Year-over-year, Non-Current Debt has increased for five consecutive quarters, with an average decline of 26.8% over the last eight quarters.
- The fastest year-over-year change in Non-Current Debt over five years came in Q3 2022 (growth of 323.4%), and the weakest in Q2 2024 (a decline of 85.1%).
- Business Quant data shows CHRS's Non-Current Debt at $37.15 million (Q1 2026), $37.05 million (Q4 2025) and $36.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 37.25 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.25 Mn |
| Mar 31, 2026 | 37.15 Mn |
| Dec 31, 2025 | 37.05 Mn |
| Sep 30, 2025 | 36.96 Mn |
| Jun 30, 2025 | 36.87 Mn |
| Mar 31, 2025 | 36.78 Mn |
| Dec 31, 2024 | 36.70 Mn |
| Sep 30, 2024 | 36.62 Mn |
| Jun 30, 2024 | 36.54 Mn |
| Mar 31, 2024 | 72.45 Mn |
| Dec 31, 2023 | 246.48 Mn |
| Sep 30, 2023 | 246.22 Mn |
| Jun 30, 2023 | 245.96 Mn |
| Mar 31, 2023 | 245.72 Mn |
| Dec 31, 2022 | 245.48 Mn |
| Sep 30, 2022 | 245.25 Mn |
| Jun 30, 2022 | 196.04 Mn |
| Mar 31, 2022 | 195.85 Mn |
| Dec 31, 2021 | 75.51 Mn |
| Sep 30, 2021 | 57.92 Mn |
Coherus Oncology Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();